Purchase this article with an account.
T. Rodallec, R. Adam, J.P. Nordmann; Pain After Scleral Buckling Surgery With or Without Ropivacaïne Sub–Tenon Injection . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5490.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: Evaluating pain after scleral buckling surgery with or without ropivacaïne sub–tenon injection at the end of procedure. Methods: 48 eyes of 48 patients with retinal detachment underwent scleral buckling by the same surgent with systematic peribulbaire anesthesia.The same procedure was realised :cryotherapy on tears and ponction just before scleral bucling.Patients were randomly assigned to have 0.2ml ropivacaïne sub–tenon injection in infero–temporal quadrant at the end of procedure (groupe 1=24), or nothing (groupe 2=24). At 6h, 12h, 24h with EVA (evaluation visual analogic), pain was evaluated by an expert who didn’t know the patients and their treatment. The same post–operative analgesic was given for groupe 1 and 2. Results:Significant differences were detected between the two groupes at 6h (p=0.0018), and 12h (p=0.03). No significant differences were detected between the two groupes at 24h (p=0.48). Evaluation visual analogic at 6h was 2.8±0.46 in groupe 1 and 5.3±0.40 in groupe 2, EVA at 12h was 2.3±0.42 in groupe 1 and 3.83±0.44 in groupe 2. EVA at 24h was 2.5±0.34 in groupe 1 and 3 ±0.53 in groupe 2. Conclusions: According to this study and to reduce pain, we propose, when it is possible, ropivacaïne sub–tenon injection at the end of procedure after scleral buckling surgery.
This PDF is available to Subscribers Only